SecSonar.com

Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Mereo BioPharma Group plc (MREO) is a Biotechnology company based in GB with a market capitalization of $55.5M. Free cash flow was negative at -$31M. This page tracks MREO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 36 employees · IPO Apr 24, 2019

Valuation

Valuation & price

$0.24 · as of May 17, 2026 · -91.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.36

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.94$1.59$0.24Jul 25Dec 25Jul 26Jul 7, 25$2.92Jul 9, 25$2.94Jul 11, 25$1.61Jul 15, 25$1.71Jul 17, 25$1.78Jul 21, 25$1.71Jul 23, 25$1.87Jul 25, 25$1.76Jul 29, 25$1.71Jul 31, 25$1.69Aug 4, 25$1.66Aug 6, 25$1.59Aug 11, 25$1.52Aug 13, 25$1.73Aug 15, 25$1.74Aug 19, 25$1.64Aug 21, 25$1.65Aug 25, 25$1.74Aug 27, 25$1.76Aug 29, 25$1.71Sep 3, 25$1.73Sep 5, 25$1.77Sep 9, 25$1.82Sep 11, 25$1.82Sep 16, 25$1.76Sep 18, 25$1.77Sep 22, 25$1.85Sep 24, 25$1.80Sep 26, 25$1.94Sep 30, 25$2.06Oct 2, 25$2.05Oct 6, 25$2.01Oct 8, 25$1.96Oct 10, 25$1.96Oct 14, 25$1.96Oct 16, 25$2.00Oct 21, 25$2.13Oct 23, 25$2.00Oct 27, 25$2.00Oct 29, 25$1.92Oct 31, 25$1.90Nov 4, 25$1.78Nov 6, 25$1.76Nov 10, 25$1.77Nov 12, 25$1.84Nov 14, 25$1.78Nov 18, 25$1.82Nov 20, 25$1.79Nov 25, 25$1.79Nov 28, 25$1.87Dec 2, 25$1.75Dec 4, 25$2.04Dec 8, 25$2.13Dec 10, 25$2.31Dec 12, 25$2.17Dec 16, 25$2.10Dec 18, 25$1.92Dec 22, 25$2.29Dec 24, 25$2.30Dec 29, 25$0.29Jan 2, 26$0.51Jan 6, 26$0.38Jan 8, 26$0.38Jan 12, 26$0.57Jan 14, 26$0.72Jan 16, 26$0.64Jan 21, 26$0.53Jan 23, 26$0.53Jan 27, 26$0.47Jan 29, 26$0.44Feb 2, 26$0.43Feb 4, 26$0.41Feb 9, 26$0.39Feb 11, 26$0.40Feb 13, 26$0.37Feb 18, 26$0.42Feb 20, 26$0.42Feb 24, 26$0.40Feb 26, 26$0.39Mar 2, 26$0.40Mar 4, 26$0.41Mar 6, 26$0.39Mar 10, 26$0.40Mar 12, 26$0.39Mar 17, 26$0.38Mar 19, 26$0.36Mar 23, 26$0.34Mar 25, 26$0.35Mar 27, 26$0.33Mar 31, 26$0.33Apr 2, 26$0.32Apr 7, 26$0.33Apr 9, 26$0.32Apr 13, 26$0.32Apr 15, 26$0.34Apr 17, 26$0.34Apr 22, 26$0.32Apr 24, 26$0.29Apr 28, 26$0.28Apr 30, 26$0.27May 4, 26$0.29May 6, 26$0.24May 8, 26$0.25May 12, 26$0.25May 14, 26$0.25May 18, 26$0.24May 20, 26$0.28May 22, 26$0.28May 28, 26$0.34Jun 1, 26$0.31Jun 3, 26$0.33Jun 5, 26$0.31Jun 9, 26$0.31Jun 11, 26$0.31Jun 15, 26$0.30Jun 17, 26$0.31Jun 22, 26$0.33Jun 24, 26$0.30Jun 26, 26$0.30Jul 2, 26$0.33
$0.2452-week range$2.94
Loading valuation history…

Fundamentals

Key fundamentals

$55.5M

Market cap

—

Revenue growth (YoY)

73.4%

Gross margin

-$31M

Free cash flow (USD)

-$40.8M

Net debt

Net cash position

7.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$-3.3MFY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$49.2MFY 2022$0.00FY 2023$10.0MFY 2024$0.00FY 2025$500.0K
$0$500K

Free cash flow by year

2016 → 2025

FY 2016$-27.4MFY 2017$-34.4MFY 2018$-23.2MFY 2019$-60.3MFY 2020$-38.6MFY 2021$-7.8MFY 2022$-48.8MFY 2023$-21.6MFY 2024$-33.5MFY 2025$-31.0M
-$27.4M-$31M

Gross margin by year

2021 → 2025

FY 202150.9%FY 202374.3%FY 202573.4%
50.9%73.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual General Meeting ResultsMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing

Questions

Frequently asked questions

What is Mereo BioPharma Group plc's market cap?

Mereo BioPharma Group plc (MREO) has a market capitalization of $55.5M.

What is MREO's P/E ratio?

A meaningful P/E ratio is not available for MREO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MREO's price-to-book (P/B) ratio?

MREO trades at 1.36 times book value per share.

Are insiders buying MREO stock?

SEC Form 4 filings show no open-market insider buys at Mereo BioPharma Group plc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ATYR

aTyr Pharma, Inc.

$53.9M

CUE

Cue Biopharma, Inc.

$57.5M

GUTS

Fractyl Health, Inc. Common Stock

$58.9M

MGX

Metagenomi, Inc. Common Stock

$51.6M

XLO

Xilio Therapeutics, Inc.

$49.8M

ELUT

Elutia Inc.

$49.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.